Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid Fluorescence-mediated tomography

Theranostics

Volumn 4, Issue 10, 2014, Pages 960-971

  Gremse, Felix ^a   Theek, Benjamin ^a   Kunjachan, Sijumon ^a   Lederle, Wiltrud ^a   Pardo, Alessa ^b   Barth, Stefan ^b,c   Lammers, Twan ^a,d,e   Naumann, Uwe ^a   Kiessling, Fabian ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Diffuse optical tomography; Drug delivery; Fluorescence mediated tomography; Micro Computed tomography; Multimodal imaging; Nanomedicine

Indexed keywords

FLUORESCENT DYE; NANOPARTICLE;

ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CHEMISTRY; HUMAN; IMAGE QUALITY; MICRO-COMPUTED TOMOGRAPHY; NUDE MOUSE; PROCEDURES; SPECTROFLUOROMETRY; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FLUORESCENT DYES; HUMANS; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; PHANTOMS, IMAGING; SPECTROMETRY, FLUORESCENCE; TISSUE DISTRIBUTION; X-RAY MICROTOMOGRAPHY;

EID: 84906850522     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.9293     Document Type: Article

References (51)

1. Baker M. Whole-animal imaging: The whole picture. Nature. 2010; 463(7283): 977-80.
2. Kunjachan S, Gremse F, Theek B, et al. Noninvasive optical imaging of nanomedicine biodistribution. ACS Nano. 2013; 7(1): 252-62.
3. Licha K, Olbrich C. Optical imaging in drug discovery and diagnostic applications. Adv Drug Deliv Rev. 2005; 57(8): 1087-108.
4. Stuker F, Ripoll J, Rudin M. Fluorescence Molecular Tomography: Principles and Potential for Pharmaceutical Research. Pharmaceutics. 2011; 3(2): 229-74.
5. Ntziachristos V. Fluorescence molecular imaging. Annu Rev Biomed Eng. 2006; 8: 1-33.
6. Ntziachristos V, Weissleder R. Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. Opt Lett. 2001; 26(12): 893-5.
7. Ale A, Ermolayev V, Herzog E, et al. FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography. Nat Methods. 2012; 9(9): 615-20.
8. Eisenblätter M, Ehrchen J, Varga G, et al. In vivo optical imaging of cellular inflammatory response in granuloma formation using fluorescence-labeled macrophages. J Nucl Med. 2009; 50(10): 1676-82.
9. Lederle W, Arns S, Rix A, et al. Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects. EJNMMI Res. 2011; 1: 26.
10. Nahrendorf M, Waterman P, Thurber G, et al. Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol. 2009; 29(10): 1444-51.
11. Rao J, Dragulescu-Andrasi A, Yao H. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol. 2007; 18(1): 17-25.
12. Al Rawashdeh W, Arns S, Gremse F, et al. Optical tomography of MMP-activity allows a sensitive non-invasive characterization of the invasiveness and angiogenesis of SCC-xenografts. Neoplasia. 2014; 16(3): 235-46.
13. Kaijzel EL, van der Pluijm G, Löwik CWGM. Whole-body optical imaging in animal models to assess cancer development and progression. Clin Cancer Res. 2007; 13(12): 3490-7.
14. Li R, Zheng K, Chen Z, et al. A Novel Tumor Targeting Drug Carrier for Optical Imaging and Therapy. Theranostics. 2014; 4(6): 642-59.
15. Abascal JFP-J, Aguirre J, Chamorro-Servent J, et al. Influence of absorption and scattering on the quantification of fluorescence diffuse optical tomography using normalized data. J Biomed Opt. 2012; 17(3): 036013.
16. Hyde D, Schulz R, Brooks D, et al. Performance dependence of hybrid x-ray computed tomography/fluorescence molecular tomography on the optical forward problem. J Opt Soc Am A Opt Image Sci Vis. 2009; 26(4): 919-23.
17. Soubret A, Ripoll J, Ntziachristos V. Accuracy of fluorescent tomography in the presence of heterogeneities: study of the normalized Born ratio. IEEE Trans Med Imaging. 2005; 24(10): 1377-86.
18. Patwardhan SV, Culver JP. Quantitative diffuse optical tomography for small animals using an ultrafast gated image intensifier. J Biomed Opt. 2008; 13(1): 011009.
19. Jacques SL. Optical properties of biological tissues: a review. Phys Med Biol. 2013; 58(11): R37.
20. Kunjachan S, Pola R, Gremse F, et al. Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines. Nano Lett. 2014; 14(2): 972-81.
21. Schober A, Nazari-Jahantigh M, Wei Y, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014; 20(4): 368-76.
22. Theek B, Gremse F, Kunjachan S, et al. Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging. J Control Release. 2014;(182): 83-9.
23. Radrich K, Ale A, Ermolayev V, et al. Improving limited-projection-angle fluorescence molecular tomography using a co-registered x-ray computed tomography scan. J Biomed Opt. 2012; 17(12): 126011.
24. Schulz RB, Ale A, Sarantopoulos A, et al. Hybrid system for simultaneous fluorescence and x-ray computed tomography. IEEE Trans Med Imaging. 2010; 29(2): 465-73.
25. Freyer M, Ale A, Schulz RB, et al. Fast automatic segmentation of anatomical structures in x-ray computed tomography images to improve fluorescence molecular tomography reconstruction. J Biomed Opt. 2010; 15(3): 036006.
26. Keereman V, Mollet P, Berker Y, et al. Challenges and current methods for attenuation correction in PET/MR. MAGMA. 2013; 26(1): 81-98.
27. Vasquez KO, Casavant C, Peterson JD. Quantitative Whole Body Biodistribution of Fluorescent-Labeled Agents by Non-Invasive Tomographic Imaging. PLoS ONE. 2011; 6(6): e20594.
28. Doleschel D, Mundigl O, Wessner A, et al. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts. J Nucl Med. 2012; 53(2): 304-11.
29. Hielscher AH. Optical tomographic imaging of small animals. Curr Opin Biotechnol. 2005; 16(1): 79-88.
30. Sevick-Muraca EM, Rasmussen JC. Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine. J Biomed Opt. 2008; 13(4): 041303.
31. Davies AJ, Christianson DB, Dixon LCW, et al. Reverse differentiation and the inverse diffusion problem. Adv Eng Softw. 1997; 28(4): 217-21.
32. Naumann U. The Art of Differentiating Computer Programs: An Introduction to Algorithmic Differentiation. Philadelphia, PA, USA: SIAM. 2012:358p.
33. Bell N, Dalton S, Olson LN. Exposing Fine-Grained Parallelism in Algebraic Multigrid Methods. SIAM J Sci Comput. 2012; 34(4): C123-C152.
34. Lin C-J. On the Convergence of Multiplicative Update Algorithms for Nonnegative Matrix Factorization. IEEE Trans Neural Netw. 2007; 18(6): 1589 -1596.
35. Cheong W-F, Prahl SA, Welch AJ. A review of the optical properties of biological tissues. IEEE J Quantum Electron. 1990; 26(12): 2166-85.
36. Goulden F, Warren FL. The Hemoglobin Content of the Blood of Mice of the RIII and CBA Strains. Cancer Res. 1944; 4(7): 421-4.
37. Ehling J, Bartneck M, Wei X, et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut. 2014.
38. Ehling J, Theek B, Gremse F, et al. Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization. Am J Pathol. 2014; 184(2): 431-41.
39. Gremse F, Grouls C, Palmowski M, et al. Virtual Elastic Sphere Processing Enables Reproducible Quantification of Vessel Stenosis at CT and MR Angiography. Radiology. 2011; 260: 709-17.
40. Arridge SR, Dorn O, Kolehmainen V, et al. Parameter and structure reconstruction in optical tomography. J Phys: Conf Ser. 2008; 135(1): 012001.
41. Arridge SR, Schotland JC. Optical tomography: forward and inverse problems. Inverse Probl. 2009; 25(12): 123010.
42. Klose AD, Hielscher AH. Quasi-Newton methods in optical tomographic image reconstruction. Inverse Probl. 2003; 19(2): 387.
43. Arridge SR, Lionheart WRB. Nonuniqueness in diffusion-based optical tomography. Opt Lett. 1998; 23(11): 882-4.
44. Harrach B. Simultaneous determination of the diffusion and absorption coefficient from boundary data. Inverse Probl Imaging. 2012; 6(4): 663-79.
45. Culver J, Akers W, Achilefu S. Multimodality Molecular Imaging with Combined Optical and SPECT/PET Modalities. J Nucl Med. 2008; 49(2): 169-72.
46. Garofalakis A, Dubois A, Kuhnast B, et al. In vivo validation of free-space fluorescence tomography using nuclear imaging. Opt Lett. 2010; 35(18): 3024-6.
47. Xing Y, Zhao J, Conti PS, et al. Radiolabeled Nanoparticles for Multimodality Tumor Imaging. Theranostics. 2014; 4(3): 290-306.
48. Ntziachristos V, Ripoll J, Wang LV, et al. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol. 2005; 23(3): 313-20.
49. Arridge SR. Optical tomography in medical imaging. Inverse Probl. 1999; 15(2): R41.
50. Lutzweiler C, Razansky D. Optoacoustic Imaging and Tomography: Reconstruction Approaches and Outstanding Challenges in Image Performance and Quantification. Sensors. 2013; 13(6): 7345-84.
51. [Internet] Prahl S. Optical absorption of hemoglobin. http://omlc.ogi.edu/spectra/hemoglobin.